Preferred Label : mirabegron;
MeSH note : structure in first source;
CISMeF synonym : YM178 cpd; YM 178; betanis;
MeSH synonym : 2-(2-aminothiazol-4-yl)-4'-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)acetanilide; Betmiga;
MeSH hyponym : YM-178;
Is substance : O;
UNII : MVR3JL3B2V;
InChIKey : PBAPPPCECJKMCM-IBGZPJMESA-N;
Origin ID : C520025;
UMLS CUI : C2983812;
CISMeF manual mappings
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/portail/jcms/c_2801252/fr/betmiga-mirabegron-antispasmodique-urinaire
https://www.has-sante.fr/portail/jcms/c_2801252/fr/betmiga
2017
false
false
false
false
France
French
evaluation of the transparency committee
Delayed-Action preparations
administration, oral
treatment outcome
mirabegron
mirabegron
urological agents
urological agents
mirabegron
urinary incontinence
urinary incontinence, urge
urinary frequency
urinary bladder, overactive
adult
adrenergic beta-3 receptor agonists
adrenergic beta-3 receptor agonists
guidelines for drug use
insurance, health, reimbursement
acetanilides
thiazoles
acetanilides
thiazoles
---
http://www.has-sante.fr/portail/jcms/c_1758554/fr/betmiga
2014
false
false
false
France
French
evaluation of the transparency committee
Delayed-Action preparations
administration, oral
treatment outcome
mirabegron
mirabegron
urological agents
urological agents
mirabegron
urinary incontinence
urinary incontinence, urge
urinary frequency
urinary bladder, overactive
adult
adrenergic beta-3 receptor agonists
adrenergic beta-3 receptor agonists
clinical trials as topic
guidelines for drug use
acetanilides
thiazoles
acetanilides
thiazoles
---
Summary Basis of Decision (SBD) for Myrbetriq
Mirabegron, 25 mg and 50 mg, tablets, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00230
2013
false
Canada
English
French
drug information
mirabegron
mirabegron
Mirabegron 25mg m/r tablet (product)
Mirabegron 50mg m/r tablet (product)
canada
drug approval
mirabegron
urinary bladder, overactive
adrenergic beta-3 receptor agonists
administration, oral
treatment outcome
controlled clinical trials as topic
adrenergic beta-3 receptor agonists
acetanilides
acetanilides
thiazoles
thiazoles
---